Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthesis and biological evaluation of new pyrazolebenzene-sulphonamides as potential anticancer agents and hCA I and II inhibitors. | Turk J Chem | 2021 | 34385849 | PubTator, text mining | PubMed |
| Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma. | J Exp Clin Cancer Res | 2021 | 34384473 | PubTator, text mining | PubMed |
| Molecular characteristics and spatial distribution of adult human corneal cell subtypes. | Sci Rep | 2021 | 34381080 | PubTator, text mining | PubMed |
| Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides. | Bioorg Chem | 2021 | 34365059 | PubTator, text mining | PubMed |
| Impact of Hypoxia over Human Viral Infections and Key Cellular Processes. | Int J Mol Sci | 2021 | 34360716 | PubTator, text mining | PubMed |
| Acid Microenvironment in Bone Sarcomas. | Cancers (Basel) | 2021 | 34359749 | PubTator, text mining | PubMed |
| Synthesis and Human Carbonic Anhydrase I, II, IX, and XII Inhibition Studies of Sulphonamides Incorporating Mono-, Bi- and Tricyclic Imide Moieties. | Pharmaceuticals (Basel) | 2021 | 34358123 | PubTator, text mining | PubMed |
| Small Residues Inhibit Homo-Dimerization of the Human Carbonic Anhydrase XII Transmembrane Domain. | Membranes (Basel) | 2021 | 34357162 | PubTator, text mining | PubMed |
| Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs. | BMC Cancer | 2021 | 34353313 | PubTator, text mining | PubMed |
| The biotin interference within interference suppressed immunoassays. | J Clin Lab Anal | 2021 | 34346119 | PubTator, text mining | PubMed |
| Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies. | J Enzyme Inhib Med Chem | 2021 | 34340614 | PubTator, text mining | PubMed |
| Terpenoids enriched ethanol extracts of aerial roots of Ceriops decandra (Griff.) and Ceriops tagal (Perr.) promote diuresis in mice. | Heliyon | 2021 | 34337186 | PubTator, text mining | PubMed |
| Identification of non-classical hCA XII inhibitors using combination of computational approaches for drug design and discovery. | Sci Rep | 2021 | 34330958 | PubTator, text mining | PubMed |
| Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders. | J Enzyme Inhib Med Chem | 2021 | 34325588 | PubTator, text mining | PubMed |
| Genome-Wide Association Study (GWAS) of dental caries in diverse populations. | BMC Oral Health | 2021 | 34311721 | PubTator, text mining | PubMed |
| Prediction of a Potential Mechanism of Intervertebral Disc Degeneration Based on a Novel Competitive Endogenous RNA Network. | Biomed Res Int | 2021 | 34307661 | PubTator, text mining | PubMed |
| Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel. | Int J Mol Sci | 2021 | 34299315 | PubTator, text mining | PubMed |
| TBC1D9: An Important Modulator of Tumorigenesis in Breast Cancer. | Cancers (Basel) | 2021 | 34298771 | PubTator, text mining | PubMed |
| AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis. | Int J Gen Med | 2021 | 34285555 | PubTator, text mining | PubMed |
| Construction and Validation of a Lung Cancer Diagnostic Model Based on 6-Gene Methylation Frequency in Blood, Clinical Features, and Serum Tumor Markers. | Comput Math Methods Med | 2021 | 34257703 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=28